Unraveling the Complexities in Nasal Vaccine Development, Manufacturing, and Device Selection
Summary: In a recent webinar, experts shared their insights on developing intranasal products and scaling them for commercial supply. The nasal delivery of vaccines is a growing field in terms of investment in research and development resources along with late-phase clinical trials. It is not a matter of “if” but “when” we will see the next nasal vaccine approved. Choosing a development and manufacturing partner with a global presence and expertise in intranasal delivery is essential for product development and commercialization.